Seeking Alpha

IDRA
Idera Pharmaceuticals, Inc. - NASDAQ

4/18/2014, 7:29 PM ET
Quote & Analysis Breaking News StockTalk
idra chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There are 2 articles on this stock available only to PRO subscribers.
Other Articles
  • Idera: A Compelling Biotech Pick For March
    EXPstocktrader Fri, Mar. 7 73 Comments

    Summary

    • In this article, I write about one of my “top picks” to consider for March; Idera Pharmaceuticals.
    • This company is working to treat autoimmune diseases and certain genetically defined forms of B-cell lymphoma.
    • The company is now developing its proprietary third generation antisense technology.
There are no Transcripts on IDRA.
IDRA vs. ETF Alternatives
Company Description

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company engaged in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.

Sector: Healthcare
Industry: Biotechnology
Country: United States